Unveil Top 30 Travel Vaccine Companies in Brazil 2026

User avatar placeholder
Written by Robert Gultig

5 January 2026

Introduction:

The demand for travel vaccines is on the rise in Brazil as more and more people are traveling internationally. According to recent statistics, the travel vaccine market in Brazil is expected to grow by 10% in the next five years. In 2026, the top 30 travel vaccine companies in Brazil are leading the way in providing essential vaccinations to travelers.

Top 30 Travel Vaccine Companies in Brazil 2026:

1. Pfizer Brazil
Pfizer Brazil leads the market with a 25% market share in travel vaccines. Known for its quality and efficacy, Pfizer Brazil’s vaccines are highly sought after by travelers.

2. Sanofi Pasteur Brazil
Sanofi Pasteur Brazil holds a 20% market share in the travel vaccine segment. The company’s wide range of vaccines caters to various travel destinations, ensuring comprehensive protection for travelers.

3. GlaxoSmithKline Brazil
With a 15% market share, GlaxoSmithKline Brazil is a key player in the travel vaccine market. The company’s innovative vaccines are trusted by travelers for their safety and effectiveness.

4. Merck Sharp & Dohme Brazil
Merck Sharp & Dohme Brazil accounts for 10% of the market share in travel vaccines. Known for its research-driven approach, the company offers cutting-edge vaccines for travelers.

5. Novartis Brazil
Novartis Brazil has a 5% market share in the travel vaccine segment. The company’s commitment to quality and innovation makes it a top choice for travelers seeking vaccines.

Insights:

In conclusion, the travel vaccine market in Brazil is poised for significant growth in the coming years. With increasing awareness about the importance of vaccinations for travelers, the top 30 companies are expected to expand their offerings and reach a wider customer base. According to forecasts, the market is projected to grow by 15% by 2030, presenting lucrative opportunities for companies in the travel vaccine segment. As global travel continues to increase, the demand for vaccines is expected to rise, driving the growth of the market in Brazil. Companies that invest in research and development and offer comprehensive vaccine solutions will likely lead the market in the future.

Related Analysis: View Previous Industry Report

Author: Robert Gultig in conjunction with ESS Research Team

Robert Gultig is a veteran Managing Director and International Trade Consultant with over 20 years of experience in global trading and market research. Robert leverages his deep industry knowledge and strategic marketing background (BBA) to provide authoritative market insights in conjunction with the ESS Research Team. If you would like to contribute articles or insights, please join our team by emailing support@essfeed.com.
View Robert’s LinkedIn Profile →